What Is NAD+? The Honest Evidence for Women

NAD+ — nicotinamide adenine dinucleotide — declines with age, and that decline is what motivates the entire category of “NAD+-boosting” products.^[1] Gallagher and Emmanuel describe those strategies as ranging from lifestyle changes to oral NAD+ precursors and, in some wellness settings, to NAD+ given by injection.^[1]

Here is the honest part most sellers skip. Compounded medications are not FDA-approved.^[2] And while a 2026 PRISMA-guided systematic review of NAD+ supplementation by Gallagher and Emmanuel in Ageing Research Reviews found that oral NR and NMN consistently demonstrated biochemical target engagement — they measurably raised NAD-related metabolites in blood and cells — Gallagher and Emmanuel concluded that the clinical effectiveness of NAD+ augmentation for anti-aging or wellness outcomes remains inconclusive.^[1]

We would rather tell you that up front than sell you a promise the evidence cannot back. Here is the straight version.

What NAD+ is

NAD+ is not a drug and not a hormone. It is a coenzyme — a helper molecule your cells already make and use. NAD+ levels decline as you get older, and Gallagher and Emmanuel identify that decline as the premise the whole NAD+-boosting category rests on.^[1]

The compounds sold to raise NAD+ are usually its precursors, or NAD+ itself given parenterally.^[1] The two precursors you will see sold are nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN).^[1] When it is offered as a treatment here, NAD+ is typically prepared as a self-administered injection or a nasal spray by a state-licensed compounding pharmacy. That compounding detail matters, and we come back to it below. NAD+ sits alongside sermorelin and B12 MIC on our Longevity & Energy page, each covered with this same candor.

What the evidence actually shows

This is the section other pages leave out, so we will be direct. The 2026 Gallagher and Emmanuel systematic review in Ageing Research Reviews searched peer-reviewed human and rodent intervention studies of NAD-related compounds published between January 2010 and October 2025.^[1]

Gallagher and Emmanuel identified 113 eligible NAD+ studies: 33 human intervention studies — 28 of them randomized — and 80 rodent studies.^[1] That ratio is worth sitting with: most of what you have heard about NAD+ was learned in animals.

In rodent models, Gallagher and Emmanuel found NAD+ augmentation was frequently associated with improvements in metabolic, mitochondrial, inflammatory, and functional outcomes, although effects varied across models and endpoints.^[1]

In humans, Gallagher and Emmanuel found oral NR and NMN consistently demonstrated biochemical target engagement, and that oral NR and NMN were generally well tolerated over weeks to months.^[1] That is a real, measurable effect: these compounds do what they say they do to a lab value.

But Gallagher and Emmanuel also found that, in those human NAD+ studies, effects on functional, metabolic, vascular, and other healthspan-relevant outcomes were heterogeneous and often null or endpoint-specific.^[1] The overall conclusion of Gallagher and Emmanuel was that NAD+ augmentation produces clear, measurable activity in the body, but that its clinical effectiveness for anti-aging or wellness outcomes remains inconclusive.^[1] Gallagher and Emmanuel called for larger, well-designed randomized NAD+ trials with longer follow-up and prespecified clinically meaningful endpoints.^[1]

That gap — between moving a number on a lab report and changing how you feel or how you age — is the honest state of NAD+ right now. Anyone telling you a vial will recharge your cells or add years to your life is describing a hope, not a demonstrated result.

If you want a rule of thumb for reading claims like these, three help: a mechanism is not an outcome; animal studies are not human results; and raising a level is not the same as feeling different. Hold every brand — including us — to those.

What the evidence says about injected NAD+

This part matters most, because injection is how NAD+ is most often sold — including here.

The 2026 Gallagher and Emmanuel systematic review in Ageing Research Reviews reported that no eligible outcomes trials evaluated intravenous or intramuscular NAD+ itself for anti-aging or wellness indications.^[1] In Gallagher and Emmanuel, one nonrandomized intravenous NMN study met the inclusion criteria, and that NMN study primarily contributed short-term safety and biomarker information rather than outcomes.^[1] Gallagher and Emmanuel specifically called for larger randomized NAD+ trials for parenteral approaches.^[1]

Read that plainly: the form of NAD+ most commonly sold is the form with the least outcomes evidence behind it. We would rather you know that before you spend anything than after.

“Compounded” is not the same as “FDA-approved”

Compounded NAD+ is prepared to a prescription by a state-licensed compounding pharmacy. Compounded medications are not FDA-approved.^[2] Compounded medications do not go through FDA regulatory review for safety, effectiveness, or quality before they are marketed.^[2] That does not make compounding a loophole or a secret — it is a long-standing, regulated part of pharmacy — but it does mean the reassurance of a full FDA approval is not there, and you deserve to know that before you spend anything.

This is the same regulatory distinction we walk through for weight medications in Are Compounded Semaglutides Safe — worth reading if you want the fuller picture of what “compounded” means for anything you are prescribed.

Why the “for women” framing, honestly

You will see NAD+ marketed heavily to women around energy and aging. We are not going to do that.

The Gallagher and Emmanuel bottom line on NAD+ — clear measurable activity, inconclusive clinical effectiveness for anti-aging and wellness outcomes — is the bottom line we apply here, and we are not going to dress it up as a women's-health breakthrough.^[1] The reason this article exists is the opposite: so that a woman researching NAD+ gets the same straight answer she would want a friend in medicine to give her, instead of the marketing version.

How care works if you pursue it

If you do want NAD+ evaluated, the process is built around a provider making the call, not a shopping cart:

You complete an online health history on your own time — the initial visit is asynchronous, so there is no appointment to book.

A medical provider licensed in your state reviews it. If NAD+ is appropriate for you, they prescribe it; if it is not, they decline, and you pay nothing.

There is a refill review at three to four weeks, then refills move to a 12-week rhythm with ongoing provider oversight.

You are never charged unless a provider approves a plan, and you can cancel any time — future cycles stop, and past payments are not refundable.

What it costs, posted plainly

We post prices in full because most of this category hopes you will not look. NAD+ is $199 for your first 4 weeks, then $239 every 28 days — or $597 for a 12-week plan billed once per term, which works out to $199 every 28 days. Plans renew every 28 days, which is 13 cycles across a year. No membership fees, no sign-up fees.

If it is not right for you

The most valuable thing a provider can do in this category is sometimes to say no — that a treatment whose clinical effectiveness is still inconclusive is not worth your money for your situation.^[1] We consider that a feature. You can see NAD+ alongside sermorelin and B12 MIC, each with the same honest treatment, on our Longevity & Energy page, and if B12 is what you are actually curious about, we lay out where it is genuinely useful in B12 and MIC Injections: What They Are.

Finding out whether any of it fits your health starts with a free online health history, reviewed by a medical provider licensed in your state — who will give you a straight answer, including a no.

See if it fits your health. Answer a few questions online — it takes a few minutes, costs nothing, and a medical provider licensed in your state reviews everything, usually within 48 hours. You are never charged unless a provider approves your plan.

Questions women actually ask